Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 654.06

+0.2%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotechwantabe who wrote (3494)	2/5/2024 12:10:13 PM
From: Biotechwantabe	of 3557

2024 guesstimate Dupi 11.588b +30% +3.5b. (COPD +?) Eylea 9.38b -5% -.5b. (HD JCODE +) Libtayo .868 +50% + .5b Cov2 .618b -100% -.618b Other 1.2b +20% .5b (cd20&bcma bi-spec+) On 2023 23.654b -.618b(cov2) = 23b + 4b = 27b 17% product revenue growth. ____——————————— 2023 guesstimate Dupi 8.68b +35% +3b Eylea 9.65b (hard to project +/-) 0 Libtayo .578 +100% +.5b. (Assuming chemo combo does well) Cov2 1.77b (0) Other 1b +20% +.2b. On 2022 21.6b -1.77b COV2 = 20b + 3.7b. = 23.7b. 18.5% product revenue increase __——_————_——— 2022 guesstimate Dupi 6.2 +33% +2b Eylea 9.4 +15% +1.4b Cov2 US +0 Other 1.4 +20% +.3b (Maybe libtayo does better?) On 2021 24.5 -7.5b COV2 + 3.7 = 20.7 ~22% product revenue increase ___———_——————- 2021 guesstimate Dupi 4b +50% +2b Eylea 8b +10% .8b Cov2 US +3b ROW +3b (possibly more but being conservative) Other 1b +20% +.2b. (Maybe libtayo does better?) On 2020 13b +9b = 22b ~70% product revenue increase

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next